Condor Capital Management Has $4.35 Million Stock Position in Danaher Co. (NYSE:DHR)

Condor Capital Management decreased its stake in shares of Danaher Co. (NYSE:DHR) by 0.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,957 shares of the conglomerate’s stock after selling 78 shares during the quarter. Condor Capital Management’s holdings in Danaher were worth $4,352,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the stock. Gilbert & Cook Inc. increased its position in shares of Danaher by 2.5% during the 4th quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock worth $401,000 after purchasing an additional 42 shares during the last quarter. Grimes & Company Inc. boosted its stake in shares of Danaher by 0.6% during the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock worth $1,696,000 after acquiring an additional 43 shares during the period. Dakota Community Bank & Trust NA boosted its stake in shares of Danaher by 16.4% during the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock worth $73,000 after acquiring an additional 45 shares during the period. Howard Capital Management Group LLC boosted its stake in shares of Danaher by 4.1% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after acquiring an additional 48 shares during the period. Finally, Spinnaker Trust boosted its stake in shares of Danaher by 1.2% during the 4th quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock worth $988,000 after acquiring an additional 50 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Danaher stock opened at $209.90 on Thursday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70. The stock has a market capitalization of $150.02 billion, a P/E ratio of 39.75, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The stock has a fifty day moving average of $218.48 and a 200-day moving average of $239.46.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the company posted $2.09 earnings per share. On average, sell-side analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.61%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is 24.24%.

Analyst Ratings Changes

Several research analysts have recently commented on DHR shares. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Scotiabank started coverage on Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price for the company. Royal Bank of Canada reiterated an “outperform” rating and set a $277.00 target price (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Robert W. Baird reduced their target price on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, The Goldman Sachs Group set a $250.00 price target on Danaher in a research note on Wednesday, January 15th. Six analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $277.76.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 10.90% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.